0000002098false00000020982025-02-282025-02-28

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): February 28, 2025

 

ACME UNITED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Connecticut

001-07698

06-0236700

(State or other jurisdiction

of incorporation or organization)

(Commission file number)

(I.R.S. Employer

Identification No.)

1 Waterview Dr, Shelton, Connecticut

 

06484

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (203) 254-6060

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Common Stock, $2.50 par value per share

 

ACU

 

NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On February 28, 2025, Acme United Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended December 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this current report.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(c) Exhibits

 

Exhibit

Number

Description

99.1

Press release dated February 28, 2025.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

ACME UNITED CORPORATION

 

By

/s/ Walter C. Johnsen

Walter C. Johnsen

Chairman and

Chief Executive Officer

Dated: February 28, 2025

By

/s/ Paul G. Driscoll

Paul G. Driscoll

Vice President and

Chief Financial Officer

Dated: February 28, 2025

 

 


Ex 99.1

 

ACME UNITED CORPORATION NEWS RELEASE

CONTACT: Paul G. Driscoll Acme United Corporation 1 Waterview Drive Shelton, CT 06484

Phone: (203) 254-6060

 

FOR IMMEDIATE RELEASE February 28, 2025

 

 

ACME UNITED REPORTS 10% INCREASE IN NET SALES FOR

THE FOURTH QUARTER OF 2024. NET INCOME ON AN ADJUSTED BASIS INCREASED 9% IN THE FOURTH QUARTER AND 23% FOR THE YEAR

 

SHELTON, CT – February 28, 2025 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended December 31, 2024 were $45.9 million compared to $41.9 million in the fourth quarter of 2023, an increase of 10%. Net sales for the year ended December 31, 2024 were $194.5 million compared to $191.5 million in 2023, an increase of 2%. Excluding the impact of the sale of the Camillus and Cuda hunting and fishing product lines on November 1, 2023, net sales for 2024 increased 6% compared to 2023.

 

Net income for the quarter ended December 31, 2024 was $1.70 million, or $0.41 per diluted share, compared to $1.56 million, or $0.40 per diluted share (as adjusted) for the same period in 2023 an increase of 9% in net income and 3% in diluted earnings per share. Including the net gain recognized on the sale of assets of the Camillus and Cuda business lines on November 1, 2023, net income was $11.2 million, or $2.87 per diluted share for the quarter ended December 31, 2023. Net income for the year ended December 31, 2024 was $10.02 million, or $2.45 per diluted share, compared to $8.15 million, or $2.23 per diluted share (as adjusted), for 2023, an increase of 23% in net income and 10% in diluted earnings per share. Including the net gain recognized on the sale of assets of Camillus and Cuda, net income was $17.8 million, or $4.86 per diluted share, for the year ended December 31, 2023.

 

Chairman and CEO Walter C. Johnsen said, “Acme United delivered a strong year in 2024. Our net sales increased 6% from our core businesses and grew overall despite the sale of the Cuda and Camillus product lines for $19.8 million in November 2023. We successfully reduced costs and implemented productivity improvements that enabled us not

1

 


Ex 99.1

only to offset the contribution from the business we sold, but also to generate 23% net income growth.

 

“Our acquisition of Elite First Aid in May 2024 has given us the products and knowledge to save lives with first responder kits and supplies. This acquisition has been fully integrated into our operations, and we are aggressively working to expand its distribution and sales in 2025.”

 

Mr. Johnsen added that the Company has strong liquidity and is positioned for further acquisitions and growth in 2025.

 

For the three months ended December 31, 2024, net sales in the U.S. segment increased 12% compared to the 2023 period. For the year ended December 31, 2024, net sales in the U.S. segment increased 2% compared to 2023. Excluding Camillus and Cuda, net sales for the year ended December 31, 2024 increased 7% compared to 2023. The sales increases for the three- and twelve-month periods were due to market share gains across multiple product lines.

 

European net sales for the three months ended December 31, 2024 decreased 1% in both U.S. dollars and local currency compared to the fourth quarter of 2023. Net sales for the year ended December 31, 2024 increased 5% in both U.S. dollars and local currency compared to 2023. Excluding Camillus and Cuda, net sales for the year ended December 31, 2024 increased 8% compared to 2023 due to market share gains in the office channel.

Net sales in Canada for the three months ended December 31, 2024 decreased 3% in U.S. dollars and were constant in local currency compared to the same period in 2023. Net sales for the year ended December 31, 2024 decreased 5% in U.S. dollars and 3% in local currency compared to 2023. Excluding Camillus and Cuda, net sales for the year ended December 31, 2024 increased 1% compared to 2023. Sales of first aid products were strong, while sales of school and office products continued to be adversely impacted by a soft economy.

 

2

 


Ex 99.1

Gross margin was 38.7% in the three months ended December 31, 2024 versus 39.1% in the comparable period last year. Gross margin was 39.3% for the year ended December 31, 2024 compared to 37.7% in 2023. The increase for the year was primarily due to productivity improvements in the Company’s manufacturing and distribution facilities.

 

The Company’s bank debt less cash as of December 31, 2024 was $21.5 million compared to $19.0 million as of December 31, 2023. During the year ended December 31, 2024, the Company paid approximately $6.1 million for the acquisition of the assets of Elite First Aid Inc., distributed $2.2 million in dividends on its common stock and generated approximately $5.0 million in free cash flow.

 

Conference Call and Webcast Information

Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Friday, February 28, 2025, at 12:00 p.m. ET. To listen or participate in a question and answer session, dial 877-407-0784. International callers may dial 201-689-8560. The confirmation code is 13751131. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.

 

About Acme United

ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Pac-Kit®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap and Elite First Aid. For more information, visit www.acmeunited.com.

 

Forward Looking Statements

The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,”

3

 


Ex 99.1

“potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.

 

Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.

 

These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of uncertainties in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) international trade policies and their impact on demand for our products and our competitive position, including the imposition of new tariffs or changes in existing tariff rates; (iv) the continuing adverse impact of inflation, including product costs, and interest rates; (v) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (vi) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, including trucker shortages, strikes, port closures or otherwise; (vii) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (viii) currency; (ix) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (x) changes in client needs and consumer spending habits; (xi) the impact of competition; (xii) the impact of technological changes including, specifically, the growth of online marketing and sales activity; and (xiii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.

# # #

 

 

4

 


Ex 99.1

 

 

 

Three Months Ended

 

 

Three Months Ended

 

Amounts in 000's except per share data

 

December 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

45,943

 

 

$

41,942

 

Cost of goods sold

 

 

28,178

 

 

 

25,538

 

Gross profit

 

 

17,765

 

 

 

16,404

 

Selling, general, and administrative expenses

 

 

15,483

 

 

 

14,311

 

Operating income

 

 

2,282

 

 

 

2,093

 

Interest expense

 

 

462

 

 

 

501

 

Interest income

 

 

(35

)

 

 

(41

)

Interest expense, net

 

 

427

 

 

 

460

 

Gain on Sale of Assets

 

 

-

 

 

 

(12,564

)

Other (income) expense, net

 

 

(8

)

 

 

31

 

Total other income, net

 

 

(8

)

 

 

(12,533

)

Income before income tax expense

 

 

1,863

 

 

 

14,166

 

Income tax expense

 

 

153

 

 

 

2,958

 

Net income

 

$

1,710

 

 

$

11,208

 

 

 

 

 

 

 

 

Shares outstanding - Basic

 

 

3,748

 

 

 

3,610

 

Shares outstanding - Diluted

 

 

4,155

 

 

 

3,909

 

 

 

 

 

 

 

 

Earnings per share - Basic

 

$

0.46

 

 

$

3.10

 

Earnings per share - Diluted

 

 

0.41

 

 

 

2.87

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation to reported Net Income (GAAP)

 

 

 

 

 

 

Net income as reported (GAAP)

 

 

1,710

 

 

 

11,208

 

Gain on Sale of business, net of tax

 

 

-

 

 

 

(9,644

)

Net income as adjusted

 

 

1,710

 

 

 

1,564

 

Adjusted Earnings per share - Basic

$

 

0.46

 

$

 

0.43

 

Adjusted earnings per share - Diluted

 

 

0.41

 

 

 

0.40

 

 

 

5

 


Ex 99.1

 

 

Year Ended

 

 

Year Ended

 

Amounts in 000's except per share data

 

December 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Net sales

 

$

194,490

 

 

$

191,501

 

Cost of goods sold

 

 

118,139

 

 

 

119,291

 

Gross profit

 

 

76,351

 

 

 

72,210

 

Selling, general, and administrative expenses

 

 

62,211

 

 

 

59,022

 

Operating income

 

 

14,140

 

 

 

13,188

 

Interest expense

 

 

2,083

 

 

 

3,096

 

Interest income

 

 

(141

)

 

 

(119

)

Interest expense, net

 

 

1,942

 

 

 

2,977

 

Gain on Sale Assets

 

 

-

 

 

 

(12,564

)

Other (income) expense, net

 

 

(95

)

 

 

41

 

Total other (income) expense, net

 

 

(95

)

 

 

(12,523

)

Income before income tax expense

 

 

12,293

 

 

 

22,734

 

Income tax expense

 

 

2,270

 

 

 

4,941

 

Net income

 

$

10,023

 

 

$

17,793

 

 

 

 

 

 

 

 

Shares outstanding - Basic

 

 

3,701

 

 

 

3,572

 

Shares outstanding - Diluted

 

 

4,099

 

 

 

3,658

 

 

 

 

 

 

 

 

Earnings per share - Basic

 

$

2.71

 

 

$

4.98

 

Earnings per share - Diluted

 

 

2.45

 

 

 

4.86

 

 

 

 

 

 

 

 

Reconciliation to reported Net Income (GAAP)

 

 

 

 

 

 

Net income as reported (GAAP)

 

 

10,023

 

 

 

17,793

 

Gain on Sale of business

 

 

-

 

 

 

(9,644

)

Net income as adjusted

 

 

10,023

 

 

 

8,149

 

Adjusted Earnings per share - Basic

$

 

2.71

 

$

 

2.28

 

Adjusted earnings per share - Diluted

 

 

2.45

 

 

 

2.23

 

 

6

 


Ex 99.1

Amounts in 000's

 

December 31, 2024

 

 

December 31, 2023

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

6,399

 

 

$

4,796

 

Accounts receivable, net

 

 

28,236

 

 

 

26,234

 

Inventories

 

 

56,254

 

 

 

55,470

 

Prepaid expenses and other current assets

 

 

4,571

 

 

 

4,773

 

Restricted cash

 

 

-

 

 

 

750

 

Total current assets

 

 

95,460

 

 

 

92,023

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

31,653

 

 

 

28,026

 

Operating lease right of use asset

 

 

4,826

 

 

 

2,002

 

Intangible assets, less accumulated amortization

 

 

20,323

 

 

 

19,001

 

Goodwill

 

 

9,908

 

 

 

8,189

 

Total assets

 

$

162,170

 

 

$

149,241

 

 

 

 

 

 

 

 

Liabilities and stockholders' equity:

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

9,005

 

 

$

12,102

 

Operating lease liability - short term

 

 

1,564

 

 

 

1,099

 

Mortgage payable - short term

 

 

437

 

 

 

419

 

Other accrued liabilities

 

 

11,866

 

 

 

12,392

 

Total current liabilities

 

 

22,872

 

 

 

26,012

 

Long term debt

 

 

17,606

 

 

 

13,105

 

Mortgage payable, net of current portion

 

 

9,868

 

 

 

10,284

 

Operating lease liability - long term

 

 

3,367

 

 

 

1,026

 

Other non-current liabilities

 

 

1,477

 

 

 

916

 

Total liabilities

 

 

55,190

 

 

 

51,343

 

Total stockholders' equity

 

 

106,980

 

 

 

97,898

 

Total liabilities and stockholders' equity

 

$

162,170

 

 

$

149,241

 

 

7

 


v3.25.0.1
Document and Entity Information
Feb. 28, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 28, 2025
Entity Registrant Name ACME UNITED CORP
Entity Central Index Key 0000002098
Entity Emerging Growth Company false
Entity File Number 001-07698
Entity Incorporation, State or Country Code CT
Entity Tax Identification Number 06-0236700
Entity Address, Address Line One 1 Waterview Dr
Entity Address, City or Town Shelton
Entity Address, State or Province CT
Entity Address, Postal Zip Code 06484
City Area Code 203
Local Phone Number 254-6060
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $2.50 par value per share
Trading Symbol ACU
Security Exchange Name NYSEAMER

Acme United (AMEX:ACU)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Acme United
Acme United (AMEX:ACU)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Acme United